-
双环醇
- names:
Bicyclol
- CAS号:
118159-48-1
MDL Number: - MF(分子式): C19H18O9 MW(分子量): 390.34
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM000529-10mg | 10mg | 99.97% | ¥ 1350.00 | ¥ 1350.00 | 2-3天 | ¥ 0.00 | ||
| YZM000529-5mg | 5mg | 99.97% | ¥ 780.00 | ¥ 780.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | 双环醇;抗HBV化合物;抗HCV化合物;百赛诺(MSDS,熔点,沸点,极化度,应用) |
| 英文别名 | Bicyclol;(Synonyms: SY801;SY-801;SY 801;118159-48-1 |
| CAS号 | 118159-48-1 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C19H18O9 |
| 分子量 Molecular Weight | 390.34 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 68 mg/mL(174.21 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
Bicyclol(CAS:118159-48-1)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | 双环醇(CAC:118159-48-1;英文名:bicyclol)是一种可以口服的抗HBV和抗HCV的小分子化合物 |
| Introduction | Bicyclol(SY 801) is a antiepatitis drug. |
| Application1 | |
| Application2 | |
| Application3 |
Bicyclol(SY 801) is a anti-hepatitis drug. Target: HBV Oral administration of bicyclol normalized the elevated serum transaminases (ALT, AST) by approximately 50% in chronic viral hepatitis B and C, and also showed certain level of inhibiting HBV and HCV replication. No noticeable adverse reaction has been observed. In combination therapy of bicyclol with interferon alpha, lamivudine and adefovir dipivoxil in HBV or HCV, bicyclol may potentiate the anti-viral efficacy and reduce YMDD mutant and side effects. In 2004 China FDA issued license to manufacture bicyclol. Since then bicyclol has been widely used to treat chronic HBV and HCV in China [1].
【1】.Walsh, S.W., Y. Wang, and A. Killian, AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta. J Pharmacol Exp Ther, 1999. 290(1): p. 220-6.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


